ARROW IPN055872Recalls & reported problems
Teleflex Incorporated · Pressure Injectable Arrowg+ard Blue Advance(R) One-Lumen PICC Kit pre-loaded with Arrow(R) VPS Precision(TM) Stylet · Class 2 · Implant
All models of ARROW (1494)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10801902159974), received between Nov 29, 2023 and Oct 30, 2024 — classified as 1 death, 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Patient Device Interaction Problem” (1 report).
8 other recalls cover devices cleared under the same FDA submission (K153487); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Patient Device Interaction Problem1
- Physical Resistance/Sticking1
- Unraveled Material1
Patient problems
- Burning Sensation1
- Diaphoresis1
- Increased Respiratory Rate1
- Insufficient Information1
- Itching Sensation1
- Nausea1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
DeathOct 30, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2024, A RISK MANAGER FOR THE HEALTH CARE FACILITY SENT TO TELEFLEX THE FOLLOWING NOTES FROM A NURSE AT THE HEALTH CARE FACILITY, "FOLLOWING DRESSING PLACEMENT ON PICC LINE, PATIENT BEGAN TO COMPLAIN OF ITCHING 'ALL OVER'. SHE ALSO COMPLAINED OF STRONG SALINE TASTE WITH FLUSH. THE 'ITCHING' GOT WORSE AND PATIENT BEGAN TO LOOK ACUTELY UNCOMFORTABLE IN THE BED. REMOVED STERILE DRAPING AND PATIENT REPORTED CONTINUING TO FEEL WORSE. AT THIS TIME, I WENT AND FOUND CHARGE NURSE AS PRIMARY NURSE WAS NOT AT THE DESK. UPON RETURNING TO THE ROOM, THE PATIENT WAS NOT RESPONDING TO VERBAL CUES AND WAS NOW NOTED TO BE DIAPHORETIC. AT THIS TIME, I CALLED OUT FOR RRT TO BE NOTIFIED. PT APPEARED TO BE AGITATED AND POSSIBLE SZ ACTIVITY. DEVIATION TO R AND POSTURING, APENIC AND PULSELESSNESS> ACLS> ROSC>." THAT SAME RISK MANAGER FOR THE HEALTH CARE FACILITY ALSO SENT TO TELEFLEX THE FOLLOWING NOTES FROM THE RRT REFERENCED ABOVE, "ON ARRIVAL TO PT ROOM, PT WAS MAINTAINING AIRWAY INDEPENDENTLY AND WAS ONLY RESPONDING TO PAINFUL STIMULI, WHILE ASSESSING FOR VITALS PATIENT WENT UNRESPONSIVE AND BECAME APNEIC. AT THAT POINT RESPIRATORY STARTED TO BAG AND WITH PULSE CHECK WE BEGAN COMPRESSIONS AN
Patient problems: Insufficient Information
MAUDE report 20570242 ↗InjuryMay 23, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED BY CLINICAL STAFF IN THE HOSPITAL THAT: THE PATIENT WAS ADMITTED FOR OSTEOMYELITIS ON (B)(6) 2024. HE WAS GETTING IV ANTIBIOTICS. ON (B)(6) 2024 A PICC LINE WAS BEING PLACED. THE RN PRESENT AT THE PROCEDURE, NOTE IS AS FOLLOWS: "AFTER INFORMED, WRITTEN CONSENT, A PREPROCEDURAL TIMEOUT WAS PERFORMED. BILATERAL ARMS BATHED WITH CHG WIPES FROM AXILLA TO FINGERTIPS, PRIOR TO PREPPING AND DRAPING PATIENT FOR PROCEDURE. ARM CIRCUMFERENCE AT INSERTION SITE WAS 28 CM. THE PATIENT'S LEFT ARM WAS PREPPED AND DRAPED IN STERILE FASHION. LOCAL ANESTHESIA WAS OBTAINED WITH 1.5 ML OF 1% LIDOCAINE. USING ULTRASOUND GUIDANCE, THE BRACHIAL VEIN WAS ACCESSED USING MICRO PUNCTURE TECHNIQUE X 1 ATTEMPT. A GUIDE WIRE WAS INTRODUCED INTO THE NEEDLE. THE NEEDLE WAS REMOVED, A 4.5 FRENCH PEEL- AWAY SHEATH WAS PLACED OVER THE WIRE AND THEN THE WIRE WAS REMOVED. A 52 CM, SINGLE LUMEN CATHETER WAS ADVANCED THROUGH THE PEEL-AWAY SHEATH AND THE SHEATH WAS REMOVED. FOLLOWING INSERTION, PATIENT COMPLAINED OF NAUSEA, WAS ABLE TO FOLLOW COMMANDS AND TURN HIS HEAD TO THE RIGHT AND HAD CLEAR EMESIS NOTED. HE BEGAN TO COMPLAIN OF "BURNING IN HIS BELLY" AND WITHIN 30 SECONDS WAS COMPLAINING OF GLOBAL IT
Patient problems: Burning Sensation; Diaphoresis; Increased Respiratory Rate; Itching Sensation; Nausea
MAUDE report 19379569 ↗MalfunctionNov 29, 2023Unraveled Material; Physical Resistance/Sticking; Unraveled Material; Physical Resistance/Sticking
IT WAS REPORTED THAT: THERE WAS RESISTANCE WHEN ATTEMPTING TO PASS THE WIRE THROUGH THE NEEDLE. WHEN IT WAS REMOVED THE WIRE WAS UNRAVELLED. THE REPORTED DEFECT WAS DETECTED DURING USE ON PATIENT. THE PATIENT CONDITION WAS REPORTED AS "FINE". NO PATIENT INJURY/CONSEQUENCE OR MEDICAL INTERVENTION REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18225868 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K153487. One submission often covers many models, so check the product and lot details in each record.
- Z-0001-2024 · Aug 10, 2023 · Open, ClassifiedArrow ErgoPack, Pressure Injectable Arrowg+ard Blue Advance Two-Lumen PICC pre-loaded with Arrow VPS Precision Stylet, REF CDC-45552-VPS2; Catheter: Percutaneous Implanted Long-Ter
- Z-1810-2019 · Apr 23, 2019 · TerminatedArrowg+ard Blue Advance PICC pre loaded with Arrow VPS" Precision Stylet Product Code: CDC 45063 VPS2
- Z-1808-2019 · Apr 23, 2019 · TerminatedArrowg+ard Blue Advance" PICC pre loaded with Arrow VPS" Precision Stylet Product Code: CDC 45041 VPS2
- Z-1807-2019 · Apr 23, 2019 · TerminatedArrowg+ard Blue Advance PICC pre loaded with Arrow VPS" Precision Stylet Product Code: CDC 44063 VPS2
- Z-1366-2019 · Dec 13, 2018 · TerminatedArrow PICC powered by Arrow VPS Precision Stylet Product Code:CDC-44052-VPS2 Product Usage: The Arrow Pressure Injectable PICC is indicated for short-term or longterm peripheral a
- Z-1365-2019 · Dec 13, 2018 · TerminatedArrow PICC powered by Arrow VPS Precision Stylet Product Code:CDC-45052-VPS2 Product Usage: The Arrow Pressure Injectable PICC is indicated for short-term or longterm peripheral a
- Z-3199-2018 · Jul 17, 2018 · Terminated4.5 Fr x 40 cm single-lumen PICC Kit, Product Code CDC-44041-VPS2, 5.5 Fr double-lumen PICC Kit, Product Code CDC-44052-VPS2
- Z-3200-2018 · Jul 17, 2018 · Terminated5.5 Fr x 40 cm double-lumen PICC Kit, Product Code CDC-44052-VPS2
Other Catheter, intravascular, therapeutic, long-term greater than 30 days devices
- Groshong NXT ClearVue Catheter 7617405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,708 reports
- Groshong NXT ClearVue Catheter 7655405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,536 reports
- PowerPICC Catheter 3174118Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall402 reports
- L-Cath™ S/L PICC S/L 26GA (1.9F) x 30cmArgon Medical Devices, Inc. · Catheter,Intravascular,Therapeutic,Long-Term Greater Than 30 Days2 recalls245 reports
- PowerPICC SOLO2 Catheter 1194108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 recalls216 reports
- Broviac 0600520Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall265 reports
- Groshong® Catheter 7717405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days279 reports
- PowerPICC® Catheters 1174108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall222 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page